MET and renal cell carcinoma: Moreover, this study presented the mechanism by which ORP5 promoted the progression of RCC: ORP5 promoted c-Cbl ubiquitination and decreased its protein level, thereby inhibiting c-Met ubiquitination and lysosomal degradation.